Related references
Note: Only part of the references are listed.
Review
Chemistry, Multidisciplinary
Gaurav Sahay et al.
Summary: This paper discusses the importance of lipid nanoparticles (LNPs) in RNA delivery. LNPs have great potential in mRNA delivery and can be used for the treatment of infectious diseases, cancer, and rare genetic diseases. The paper introduces the core features of LNPs, the theory and methods of LNP self-assembly, the components and overall attributes of LNPs, and provides an outlook on the future of RNA therapies.
ACCOUNTS OF CHEMICAL RESEARCH
(2022)
Article
Chemistry, Medicinal
Mingyuan Li et al.
Summary: The current COVID-19 epidemic has accelerated the application of mRNA technology, highlighting challenges in overcoming mRNA instability in human physiological environments. Research has also shown that mRNA has potential applications beyond COVID-19 vaccines, such as in treating other diseases and genetic disorders.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2022)
Article
Biochemistry & Molecular Biology
Aswathy Chandran et al.
Summary: A novel assay using a photoconvertible fusion protein identified autophagy inducers that either alleviated or exacerbated neurotoxicity in different cellular models of amyotrophic lateral sclerosis, challenging the notion that autophagy stimulation can be used as a one-size-fits-all therapy for neurodegenerative diseases.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2022)
Article
Chemistry, Medicinal
Nicholas R. Larson et al.
Summary: This study investigates the effect of solution pH on cationic lipid nanoparticles (LNPs) containing mRNA. The results show that at low pH values, mRNA-LNPs have higher transfection efficiency and stability, but are more prone to aggregation.
JOURNAL OF PHARMACEUTICAL SCIENCES
(2022)
Review
Biochemistry & Molecular Biology
Karen Anthony
Summary: This article reviews the common RNA-based drug modalities and their current and potential applications in neurological diseases. It highlights the rapid progress in rare genetic diseases and neurodegenerative disorders, but also the significant challenge of safe and effective delivery to the brain. It discusses the emergence of individualized RNA-based therapies for ultra-rare diseases and the potential application in more common conditions like Alzheimer's disease and stroke. The untapped potential in behavioral disorders and central nervous system tumors is also mentioned.
Review
Pharmacology & Pharmacy
Sivakumar Ramachandran et al.
Summary: This article summarizes the various delivery strategies explored for mRNA vaccines, including different carriers and formulation technologies, as well as the successful cases of COVID-19 vaccines. However, there is still a need to improve the storage stability of these vaccines for transportation to developing countries at low temperatures.
PHARMACEUTICAL MEDICINE
(2022)
Article
Medicine, Research & Experimental
Cameron Webb et al.
Summary: The COVID-19 pandemic has led to the rapid development of mRNA vaccines, thanks to the modular nature of mRNA sequences and lipid nanoparticle (LNP) technology. The success of mRNA vaccines opens up possibilities for future RNA medicines, but there is already a strain on manufacturing capacity, which will be exacerbated by the development of other mRNA drugs in the near future.
MOLECULAR PHARMACEUTICS
(2022)
Article
Biochemistry & Molecular Biology
Marius W. Baeken et al.
Summary: EGFP is commonly used in life sciences research, but this study found that ERN1 targets a specific RNA motif in EGFP mRNA. Introducing a silent mutation in EGFP mRNA prevented ERN1-dependent mRNA decay. Therefore, caution should be exercised when interpreting results using EGFP as a reporter gene in studies involving UPR pathway upregulation, and a mutant lacking the ERN1 target motif may be more suitable for such research.
JOURNAL OF CELLULAR BIOCHEMISTRY
(2022)
Article
Chemistry, Multidisciplinary
Bram Bogaert et al.
Summary: With the recent clinical approval of siRNA-based drugs and COVID-19 mRNA vaccines, the potential of RNA therapeutics has gained widespread acceptance. Researchers have developed a novel type of lipid-based nanocarrier called CADosomes, which can efficiently deliver mRNA to target cells and have shown promising results in both in vitro and in vivo studies. This versatile and straightforward approach has the potential to revolutionize drug combination therapies.
JOURNAL OF CONTROLLED RELEASE
(2022)
Article
Materials Science, Biomaterials
James Forster et al.
Summary: In recent years, significant progress has been made in the engineering of mRNA lipid nanoparticle vaccines, but there is still limited understanding of their immunogenicity. A design-driven approach is needed to determine the biophysical characteristics that drive nanoparticle immunogenicity. This study investigated the activation of NLRP3 inflammasomes by different lipid compositions in mRNA lipid nanoparticles and found that specific combinations of lipid types significantly influenced their activation.
BIOMATERIALS SCIENCE
(2022)
Article
Biology
Manuel J. Carrasco et al.
Summary: The study reports a method that can predict the pKa of lipid nanoparticles (LNPs) from the structure of the ionizable lipid, and investigates the delivery efficiency and factors influencing LNPs both in vitro and in vivo. It was also found that LNPs with more negative charge lead to higher off-target systemic mRNA expression.
COMMUNICATIONS BIOLOGY
(2021)
Article
Chemistry, Physical
Shuai Liu et al.
Summary: The study successfully delivered mRNA or single-guide RNA for gene editing in vivo using combinatorially synthesized ionizable phospholipids. Optimized iPhos lipids can change shapes in endosomal acidic environments to facilitate the release of gene editing materials. When working synergistically with helper lipids, iPhos lipids can achieve targeted delivery to specific organs.
Review
Pharmacology & Pharmacy
Nuannuan Li et al.
Summary: This paper systematically summarizes the use of RNA-based nano-delivery systems using biogenic materials for cancer therapy, which are much more compatible and less toxic compared to synthetic polymers. This review is expected to provide a valuable reference for researchers in the field of biogenic delivery and RNA-based therapies for cancer treatment.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Chemistry, Multidisciplinary
Rumiana Tenchov et al.
Summary: Lipid nanoparticles (LNPs) have become promising vehicles in the pharmaceutical industry for delivering various therapeutics, particularly highlighted in the COVID-19 mRNA vaccines. LNPs exhibit versatility and physical stability, allowing for targeted delivery of therapeutic drugs to specific locations within the body. Liposomes, an early version of LNPs, have already been widely applied in medical practice.
Review
Pharmacology & Pharmacy
Kenneth K. W. To et al.
Summary: mRNA-based therapeutics and vaccines have become a disruptive new drug class for various applications. Extensive research efforts have been made to optimize mRNA constructs and preparation procedures to overcome obstacles hindering their clinical applications. Further advancements in mRNA design and delivery technologies are needed to broaden the scope and usefulness of this new class of drugs.
EXPERT OPINION ON DRUG DISCOVERY
(2021)
Review
Cell Biology
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY
(2020)
Article
Nanoscience & Nanotechnology
Qiang Cheng et al.
NATURE NANOTECHNOLOGY
(2020)
Review
Biochemistry & Molecular Biology
Ngonidzashe Ruwizhi et al.
Article
Obstetrics & Gynecology
Hiroyuki Seki
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
(2018)
Article
Multidisciplinary Sciences
Marianna Yanez Arteta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2018)
Review
Pharmacology & Pharmacy
Mikhail Durymanov et al.
FRONTIERS IN PHARMACOLOGY
(2018)
Review
Pharmacology & Pharmacy
Xinwei Cheng et al.
ADVANCED DRUG DELIVERY REVIEWS
(2016)
Review
Biochemistry & Molecular Biology
Thomas Schlake et al.
Review
Biophysics
Peter A. Leventis et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 39
(2010)
Review
Chemistry, Multidisciplinary
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE
(2006)
Review
Chemistry, Multidisciplinary
SB Zhang et al.
JOURNAL OF CONTROLLED RELEASE
(2004)
